Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension
A Chaouat, F Coulet, C Favre, G Simonneau… - Thorax, 2004 - thorax.bmj.com
Thorax, 2004•thorax.bmj.com
Dexfenfluramine associated pulmonary arterial hypertension occurring in a patient with
hereditary haemorrhagic telangiectasia related to a mutation within the endoglin gene is
described. This report highlights the critical role of the TGF-β signalling pathway in this
condition.
hereditary haemorrhagic telangiectasia related to a mutation within the endoglin gene is
described. This report highlights the critical role of the TGF-β signalling pathway in this
condition.
Dexfenfluramine associated pulmonary arterial hypertension occurring in a patient with hereditary haemorrhagic telangiectasia related to a mutation within the endoglin gene is described. This report highlights the critical role of the TGF-β signalling pathway in this condition.
thorax.bmj.com